Clinical Trial

Type I Diabetes and Non-surgical Periodontal Treatment

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Current evidence suggests a bidirectional association between periodontitis and diabetes. Periodontal therapy improves short term HbA1c levels and is safe to perform. Most studies are focused on type 2 Diabetes. Literature about the correlation between periodontitis and type 1 diabetes is scarce, since no randomized clinical trials have been performed. The objective of the present clinical investigation is to evaluate the effects of nonsurgical treatment of periodontal disease on glycemic variability in patients with type 1 diabetes (T1DM). The hypothesis is that nonsurgical periodontal therapy affects glycemic variability in terms of time spent in hyperglycemia.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-10-03; most recent amendment 2024-12-03.
Status change: Not Yet Recruiting → Active, Not Recruiting 2024-12-03
Status change: Recruiting → Not Yet Recruiting 2022-10-06
Trial Details
NCT Number NCT05569525
Lead Sponsor University of Florence
Conditions Type 1 Diabetes, Periodontitis, Periodontal Diseases, Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 1
Enrollment 100 participants
Start Date 2022-11-06
Primary Completion 2023-11-10 (estimated)
Study Completion 2025-12-10 (estimated)
Updated on ClinicalTrials.gov 2024-12-06